( NASDAQ-NMS:ARRY )

News from array biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 19, 2016, 15:26 ET Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress

 Array BioPharma Inc. (NASDAQ: ARRY) today announced that results from a Phase 2 study of ARRY-797 will be presented at the 2016 European...


Aug 09, 2016, 02:01 ET AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer

 AstraZeneca (LON/STO/NYSE: AZN) today announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in...


Jun 30, 2016, 16:00 ET Array BioPharma Submits Binimetinib New Drug Application to U.S. FDA

 Array BioPharma (Nasdaq:  ARRY) today announced the submission of a New Drug Application (NDA) for binimetinib in patients with advanced...


Jun 06, 2016, 14:15 ET Array Presents Full Results from Phase 3 NEMO Study

 Array BioPharma (Nasdaq: ARRY) announced full results at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago...


Jun 04, 2016, 09:00 ET Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial

 Array BioPharma (Nasdaq: ARRY), Pierre Fabre and Merck KGaA, Darmstadt, Germany, today jointly initiated the BEACON CRC (Binimetinib,...


Jun 04, 2016, 09:00 ET Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks

 Array BioPharma (Nasdaq: ARRY) announced today updated results from a Phase 2 study of the combination of encorafenib and cetuximab, with or...


May 18, 2016, 17:05 ET Array BioPharma Announces Key Data from NRAS-mutant Melanoma and BRAF-mutant Colorectal Cancer ASCO 2016 Presentations

 Array BioPharma (NASDAQ: ARRY) will present additional data on its late-stage candidates binimetinib and encorafenib in NRAS-mutant melanoma...


Mar 01, 2016, 12:53 ET Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual...


Feb 01, 2016, 11:56 ET Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma

Dana-Farber Cancer Institute today announced an immuno-oncology collaboration with potential applicability in a wide range of oncology indications...


Dec 16, 2015, 06:30 ET Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma

 Array BioPharma (Nasdaq: ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with...


Dec 16, 2015, 06:30 ET Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma

 Array BioPharma (Nasdaq: ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with...


Nov 24, 2015, 15:59 ET Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Piper Jaffray Annual...


Sep 28, 2015, 07:00 ET Clinical Data Presented On Binimetinib And Encorafenib In Melanoma

 Clinical trial results from Array BioPharma's (Nasdaq:  ARRY) wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib,...


Sep 25, 2015, 08:00 ET Array BioPharma To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma And Colorectal Cancer On September 28, 2015

 Array BioPharma Inc. (Nasdaq:  ARRY) will hold a conference call to discuss preliminary results from two melanoma trials and a colorectal...


Sep 11, 2015, 08:00 ET Array BioPharma Announces Clinical Data Presentations At The 2015 European Cancer Congress

 Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on encorafenib and binimetinib at the 2015 European Cancer Congress (ECC),...


Sep 10, 2015, 17:18 ET Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley Global...


Sep 08, 2015, 08:00 ET Array BioPharma Names Patricia Henahan As Chief Financial Officer

 Array BioPharma (NASDAQ: ARRY) announced today that it has appointed Patricia Henahan to the position of Chief Financial Officer. Ms. Henahan...


May 04, 2015, 07:00 ET Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the third quarter of its fiscal year ending June 30, 2015. Ron Squarer, Chief...


Feb 03, 2015, 08:00 ET Array Biopharma Reports Financial Results For The Second Quarter Of Fiscal 2015

Array BioPharma Inc. (NASDAQ: ARRY) today...


Aug 12, 2014, 07:00 ET Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014. Ron...


Apr 23, 2014, 13:22 ET Binimetinib Continues To Advance In Clinical Development

 Following the recent announcement by Novartis and GlaxoSmithKline that they have entered into a definitive agreement to exchange certain...


Feb 18, 2014, 12:45 ET Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the RBC Capital Markets Global...


Feb 04, 2014, 08:00 ET Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the second quarter of its fiscal year ending June 30, 2014. Revenue for the...


Dec 09, 2013, 12:00 ET Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting

 Earlier today, Array BioPharma Inc. (NASDAQ: ARRY) announced updated clinical safety and efficacy data on ARRY‑614 in patients with...


Dec 09, 2013, 08:30 ET Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting

Array BioPharma Inc. (NASDAQ: ARRY) announced positive data for newly named filanesib (ARRY-520) as a single agent and in combination with...